156 related articles for article (PubMed ID: 11758652)
1. Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.
Higaki K; Yata T; Sone M; Ogawara K; Kimura T
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):231-40. PubMed ID: 11758652
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers.
Lindmark T; Nikkilä T; Artursson P
J Pharmacol Exp Ther; 1995 Nov; 275(2):958-64. PubMed ID: 7473188
[TBL] [Abstract][Full Text] [Related]
3. Absorption characteristics of compounds with different molecular weights after application to the unilateral kidney surface in rats.
Nishida K; Tomiyama N; Mukai T; Nakashima M; Sasaki H; Nakamura J
Eur J Pharm Biopharm; 2004 Nov; 58(3):705-11. PubMed ID: 15451548
[TBL] [Abstract][Full Text] [Related]
4. Enhancement potential of sucrose laurate (L-1695) on intestinal absorption of water-soluble high molecular weight compounds.
Onishi H; Imura Y; Uchida M; Machida Y
Curr Drug Deliv; 2012 Sep; 9(5):487-94. PubMed ID: 22520068
[TBL] [Abstract][Full Text] [Related]
5. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):884-93. PubMed ID: 16226752
[TBL] [Abstract][Full Text] [Related]
6. Does bacitracin have an absorption-enhancing effect in the intestine?
Gotoh S; Nakamura R; Nishiyama M; Fujita T; Yamamoto A; Muranishi S
Biol Pharm Bull; 1995 May; 18(5):794-6. PubMed ID: 7493005
[TBL] [Abstract][Full Text] [Related]
7. Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: assessment of molecular weight dependence and demonstration of transport routes.
Lindmark T; Schipper N; Lazorová L; de Boer AG; Artursson P
J Drug Target; 1998; 5(3):215-23. PubMed ID: 9606011
[TBL] [Abstract][Full Text] [Related]
8. Absorption enhancement of poorly absorbed hydrophilic compounds from various mucosal sites by combination of mucolytic agent and non-ionic surfactant.
Takatsuka S; Morita T; Horikiri Y; Yamahara H; Saji H
Int J Pharm; 2007 Jun; 338(1-2):87-93. PubMed ID: 17317052
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane.
Uchiyama T; Yamamoto A; Hatano H; Fujita T; Muranishi S
Biol Pharm Bull; 1996 Dec; 19(12):1618-21. PubMed ID: 8996651
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial use of sodium laurate with taurine or L-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages.
Miyake M; Oka Y; Minami T; Toguchi H; Odomi M; Ogawara K; Higaki K; Kimura T
J Pharm Sci; 2003 Apr; 92(4):911-21. PubMed ID: 12661076
[TBL] [Abstract][Full Text] [Related]
11. Water-in-oil microemulsions containing medium-chain fatty acids/salts: formulation and intestinal absorption enhancement evaluation.
Constantinides PP; Welzel G; Ellens H; Smith PL; Sturgis S; Yiv SH; Owen AB
Pharm Res; 1996 Feb; 13(2):210-5. PubMed ID: 8932438
[TBL] [Abstract][Full Text] [Related]
12. Absorption characteristics of model compounds from the small intestinal serosal surface and a comparison with other organ surfaces.
Nishida K; Kuma A; Fumoto S; Nakashima M; Sasaki H; Nakamura J
J Pharm Pharmacol; 2005 Aug; 57(8):1073-7. PubMed ID: 16102265
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of drug absorption via the rectal route.
Muranishi S
Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):763-72. PubMed ID: 6397676
[TBL] [Abstract][Full Text] [Related]
14. Zinc absorption in experimental osmotic diarrhea: effect of long-chain fatty acids.
Lee SY; Wapnir RA
J Trace Elem Electrolytes Health Dis; 1993 Mar; 7(1):41-6. PubMed ID: 8400847
[TBL] [Abstract][Full Text] [Related]
15. Improved synthesis of quaternary ammonium-chitosan conjugates (N+ -Ch) for enhanced intestinal drug permeation.
Zambito Y; Zaino C; Uccello-Barretta G; Balzano F; Di Colo G
Eur J Pharm Sci; 2008 Apr; 33(4-5):343-50. PubMed ID: 18296036
[TBL] [Abstract][Full Text] [Related]
16. Impact of Dietary Intake of Medium-Chain Triacylglycerides on the Intestinal Absorption of Poorly Permeable Compounds.
Kataoka M; Ohi Y; Sakanoue K; Minami K; Higashino H; Yamashita S
Mol Pharm; 2020 Jan; 17(1):212-218. PubMed ID: 31756103
[TBL] [Abstract][Full Text] [Related]
17. Labrasol
Heade J; Maher S; Bleiel SB; Brayden DJ
J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant.
Takatsuka S; Kitazawa T; Morita T; Horikiri Y; Yoshino H
Eur J Pharm Biopharm; 2006 Jan; 62(1):52-8. PubMed ID: 16289777
[TBL] [Abstract][Full Text] [Related]
19. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
Fetih G; Lindberg S; Itoh K; Okada N; Fujita T; Habib F; Artersson P; Attia M; Yamamoto A
Int J Pharm; 2005 Apr; 293(1-2):127-35. PubMed ID: 15778050
[TBL] [Abstract][Full Text] [Related]
20. Studies on the intestinal absorption of low molecular weight heparin using saturated fatty acids and their derivatives as an absorption enhancer in rats.
Mori S; Matsuura A; Rama Prasad YV; Takada K
Biol Pharm Bull; 2004 Mar; 27(3):418-21. PubMed ID: 14993814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
